“Kenneth Baum is a stand-out name” in “complex medical and scientific matters” with “strong trial advocacy skills to boot.” – The Legal 500
"[Ken Baum] is really just top-notch when it comes to expert development – a go-to guy when it comes to having connections and really being able to understand the medical science." – Chambers USA (ranked 2018-2022)
Ken brings a highly specialized skill set to defending claims brought against drug and medical device manufacturers. A graduate of both Yale Law School and the Yale University School of Medicine, Ken is widely regarded by clients and his peers as one of the nation’s leading practitioners in the products liability arena. Clients reporting to The Legal 500 repeatedly single out Ken as a “very hardworking, very skilled trial lawyer,” and a key practitioner in products liability and mass tort defense.
With a unique ability to synthesize and convey complex scientific and medical issues, Ken leads national science and expert teams in high-profile products liability litigations, including Vioxx® (Merck), Sprint Fidelis® (Medtronic), Seroquel® (AstraZeneca), gadolinium contrast dye (Bayer), Fosamax® (Merck), Mirena® (Bayer), and Zostavax® (Merck). Clients turn to Ken to depose key expert and treating physician witnesses, and his depositions have repeatedly led to litigation-ending Daubert rulings. Ken also is a pillar of bellwether trial teams, crafting case strategies and witness examinations that have led to numerous trial victories and, ultimately, the dismissal of thousands of cases nationwide.